Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly

Citation
J. Mikkelsson et al., Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly, ART THROM V, 19(10), 1999, pp. 2573-2578
Citations number
44
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
ISSN journal
10795642 → ACNP
Volume
19
Issue
10
Year of publication
1999
Pages
2573 - 2578
Database
ISI
SICI code
1079-5642(199910)19:10<2573:GIPPAW>2.0.ZU;2-B
Abstract
Glycoprotein IIIa (GPIIIa) has a key role in the aggregation of thrombocyte s, and it also mediates intimal hyperplasia after endothelial injuries; the possible association of the Pl(A1/A2) polymorphism of the gene for GPIIIa with coronary thrombosis and with the progression of coronary artery diseas e (CAD) is still to be confirmed. Therefore, the association of the PIA pol ymorphism with the development of coronary atherosclerosis, coronary narrow ing, and myocardial infarction (MI) was studied in a prospective, consecuti ve autopsy series of 300 middle-aged, white Finnish men (33 to 69 years) su ffering sudden out-of-hospital or violent death. Coronary atherosclerosis w as measured morphometrically and the coronary stenosis percentage determine d from a cast rubber model of the coronary tree. We found a significant inv erse relation (P=0.01) between the Pl(A2)-positive genotype and coronary ar tery stenosis. The frequency of possessing the Pl(A2) allele was significan tly (odds ratio [OR] 0.45, 95% confidence interval [CI] 0.22 to 0.98) lower among men with >50% coronary stenosis (18.3%) than among those with <25% s tenosis (32.9%). Although the Pl(A) polymorphism was not directly associate d with MI, the Pl(A2) allele was present in 11 of the 22 men (50%) with MI and coronary thrombosis (OR 6.6, 95% CI 2.1 to 22.8) but in only 6 of the 4 7 (12.8%) with MI associated with severe stenosis in the absence of thrombo sis. In Line with this result, men possessing the Pl(A2) allele also had a larger area of fissured and ulcerated complicated lesions in their coronary arteries (P<0.05). The present results suggest that the Pl(A) polymorphism is involved in the development of CAD and MI. Men with the Pl(A2) allele m ay harbor more thin-walled, vulnerable coronary plaques, plaques prone to r upture, leading to massive, fatal thrombosis. In contrast, men homozygous f or the Pl(A1) allele may more often show stable plaques and present with in farction caused by progressive coronary stenosis.